Roche enters $2.3 billion deal with Nurix for cancer drug
Investing.com Gold reports: Roche enters $2.3 billion deal with Nurix for cancer drug. Full body text was unavailable at ingest time, so this brief is based on headline context.
Investing.com Gold reports: Roche enters $2.3 billion deal with Nurix for cancer drug. Full body text was unavailable at ingest time, so this brief is based on headline context.